CytoDyn (CYDY) Tax Provisions (2018 - 2019)

CytoDyn (CYDY) posted Tax Provisions of -$81.0 for Q2 2019, up 100.0% on a QoQ basis from -$2.8 million in Q4 2018.

CytoDyn (CYDY) Tax Provisions (2018 - 2019) Analysis & Trends

CytoDyn's Tax Provisions history runs 2 years deep, the most recent figure standing at -$81.0 for Q2 2019.

Quarterly Tax Provisions changed N/A year-over-year to -$81.0 in Q2 2019, while the trailing twelve-month figure through Feb 2020 was -$81.0 (up 100.0% YoY) and the FY2019 annual result came in at -$2.8 million, changed N/A from the prior year.
Tax Provisions was -$81.0 for Q2 2019 at CytoDyn, up from -$2.8 million in the prior quarter.
Across five years, Tax Provisions topped out at -$81.0 in Q2 2019 and bottomed at -$2.8 million in Q4 2018.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	125,146.46
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	31.86 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	188,883.60
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	221.50 Mn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	104.00 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	179.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	CytoDyn	267.79 Mn	267.79 Mn	-	-

Historic Data

Download Data

Date	Value
May 31, 2019	-81.00
Nov 30, 2018	-2.83 Mn